Recent developments in the pharmacotherapy of mood disorders.
Abstract
This article reviews recent developments in the pharmacotherapy of mood disorders. Pharmacotherapy is the best studied and most widely validated approach for acute phase treatment and prevention of relapse-recurrence for patients with major depression, dysthymia, and bipolar affective disorder. Antidepressants are also the mainstay of inpatient treatment and, when considered together with electroconvulsive therapy, represent the first line of treatment for the most severe and incapacitating forms of depression. Similarly, pharmacotherapy with mood stabilizers is the first line of treatment for bipolar depression and mania. Despite such efficacy, problems associated with pharmacotherapy include acceptability, tolerability, adherence, incomplete remission, and high rates of recurrence after drug discontinuation. Moreover, a small subset of patients do not respond to multiple medication trials.
Cites (9)
- National Institute of Mental Health Treatment of Depression Collaborative Research Program: General Effectiveness of TreatmentsElkin, Irene · 1989 · Archives of General Psychiatry
- Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder: Remission, Recovery, Relapse, and RecurrenceFrank, Ellen · 1991 · Archives of General Psychiatry
- Time to Recovery, Chronicity, and Levels of Psychopathology in Major Depression: A 5-Year Prospective Follow-up of 431 SubjectsKeller, Martin B. · 1992 · Archives of General Psychiatry
- Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH Treatment of Depression Collaborative Research Program1991 · American Journal of Psychiatry
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.Song, F, Freemantle, N, Sheldon, T A, House, A, Watson, P, Long, A, Mason, J · 1993 · BMJ
- Tranylcypromine versus imipramine in anergic bipolar depression1991 · American Journal of Psychiatry
- Relapse after recovery from unipolar depression: a critical reviewBelsher, Gayle, Costello, Charles G. · 1988 · Psychological Bulletin
- Venlafaxine for Treatment-Resistant Unipolar DepressionNIERENBERG, ANDREW A., FEIGHNER, JOHN P., RUDOLPH, RICHARD, COLE, JONATHAN O., SULLIVAN, JOANNE · 1994 · Journal of Clinical Psychopharmacology
- Do Antidepressant and Antianxiety Drugs Increase Chronicity in Affective Disorders?Fava, Giovanni A. · 2010 · Psychotherapy and Psychosomatics
Cited by (15)
- Behavioral activation treatment for depression: returning to contextual rootsJacobson, Neil S., Martell, Christopher R., Dimidjian, Sona · 2001 · Clinical Psychology: Science and Practice
- Cognitive Therapy vs Medications in the Treatment of Moderate to Severe DepressionDeRubeis, Robert J., Hollon, Steven D., Amsterdam, Jay D., Shelton, Richard C., Young, Paula R., Salomon, Ronald M., O’Reardon, John P., Lovett, Margaret L., Gladis, Madeline M., Brown, Laurel L. et al. · 2005 · Archives of General Psychiatry
- Treating Depression in Predominantly Low-Income Young Minority Women: A Randomized Controlled TrialMiranda, Jeanne, Chung, Joyce Y., Green, Bonnie L., Krupnick, Janice, Siddique, Juned, Revicki, Dennis A., Belin, Tom · 2003 · JAMA
- Treatment and prevention of depressionHollon, Steven D., Thase, Michael E., Markowitz, John C. · 2002 · Psychological Science in the Public Interest
- Treatment resistant depression: methodological overview and operational criteriaSouery, D, Amsterdam, J, de Montigny, C, Lecrubier, Y, Montgomery, S, Lipp, O, Racagni, G, Zohar, J, Mendlewicz, J · 1999 · European Neuropsychopharmacology
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent developments in the pharmacotherapy of mood disorders. https://app.cochat.ai/papers/10.1037//0022-006x.64.4.646
- The paper
- Thase, M. E., & Kupfer, D. J. (1996). Recent developments in the pharmacotherapy of mood disorders. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.64.4.646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.